Therapeutic agents for the treatment of AD currently available on the market include acetylcholinesterase inhibitors, NMDA receptor antagonists, new monoclonal antibody drugs, or combinations of these drugs [4]. This evidence concerns the gene ACHE and Alzheimer disease.